Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WAVERLEY PHARMA INC. Proxy Solicitation & Information Statement 2020

Jun 5, 2020

47413_rns_2020-06-05_921a0455-b897-4825-8387-934038b29336.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

WAVERLEY PHARMA INC. 4-1250 Waverley Street Winnipeg, Manitoba R3T 6C6

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE is hereby given that the annual and special meeting (the “Meeting”) of the shareholders of Waverley Pharma Inc. (the “Corporation”) will be held in Winnipeg, Manitoba, at 4-1250 Waverley Street, on Thursday, June 25, 2020 at 11:00 a.m. (Central Daylight time) for the following purposes:

  1. to receive and consider the audited financial statements of the Corporation for the period ended December 31, 2019 together with the auditors’ report thereon;

  2. to elect three (3) directors for the ensuing year, namely Dr. Albert D. Friesen, Hellen Siwanowicz, and P. Marcus Enns;

  3. to appoint auditors for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors;

  4. to re-approve the Corporation’s 10% rolling Stock Option Plan; and

  5. to transact such further or other business as may properly come before the Meeting or any adjournment thereof.

As a result of heightened health and safety concerns related to the COVID-19 pandemic, in person attendance at the Meeting will be limited to registered shareholders, duly appointed proxyholders, and essential personnel. The Corporation strongly encourages shareholders not to attend the Meeting in person and to consult the recommendations of the Public Health Agency of Canada, Manitoba Health and local public health authorities for preventing the spread of COVID-19 through the practice of physical distancing. The Corporation encourages shareholders to vote their common shares prior to the Meeting following the instructions set out in the enclosed Management Proxy Circular and Proxy.

Shareholders unable to attend the Meeting by teleconference are requested to read the enclosed Management Proxy Circular and Proxy, and then complete and deposit the Proxy together with the power of attorney or other authority, if any, under which it was signed or a notarially certified copy thereof with the Corporation’s transfer agent, Computershare Trust Company of Canada, of 100 University Avenue, Toronto, Ontario, M5J 2Y1 at least 48 hours (excluding Saturdays, Sundays and statutory holidays) before the time of the Meeting. Unregistered shareholders who received the Proxy through an intermediary must deliver the Proxy in accordance with the instructions given by such intermediary.

NOTES:

  1. Holders of common shares of the Corporation are requested to sign and return, in the envelope provided for that purpose, the accompanying Proxy for use at the Meeting.

  2. Only holders of common shares of the Corporation of record at the close of business on May 12, 2020 will be entitled to vote at the Meeting.

DATED at Winnipeg, Manitoba, this 12th day of May, 2020.

BY ORDER OF THE BOARD OF DIRECTORS

(Signed) “ Albert D. Friesen

Dr. Albert D. Friesen Chairman